INTRODUCTION This Management's Discussion and Analysis dated July 13, 2023 (this "MD&A"), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the "Interim Financial Statements") of Organigram Holdings Inc. (the "Company" or "Organigram") for the three and nine months ended May 31, 2023 ("Q3 Fiscal 2023") and the audited annual consolidated financial statements for the year ended August 31, 2022 (the "Annual Financial Statements" together with the Interim Fin ...

Organigram Holdings Inc. (NASDAQ:OGI) Q2 2023 Results Conference Call April 12, 2023 8:00 AM ET Company Participants Max Schwartz - Director, IR Beena Goldenberg - CEO Derrick West - CFO Conference Call Participants Andrew Partheniou - Stifel GMP Tamy Chen - BMO Capital Markets Frederico Gomes - ATB Capital Markets Aaron Grey - Alliance Global Partners Michael Freeman - Raymond James Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome ev ...

INTRODUCTION Financial information in this MD&A is based on the Interim Financial Statements of the Company, and has been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting as issued by the International Accounting Standards Board ("IASB"), unless otherwise stated. All financial information in this MD&A is expressed in thousands of Canadian dollars ("$"), except for share and per share calculations, references to $ millions and $ billions, per gram ("g") or kilogram ...

Organigram Holdings Inc. (NASDAQ:OGI) Q1 2023 Results Conference Call January 12, 2023 8:00 AM ET Company Participants Craig MacPhail - IR, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Andrew Partheniou - Stifel Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Ty Collin - Eight Capital Michael Freeman - Raymond James Matt Bottomley - Canaccord Genuity Operator Good morning. My name is Rob, and I w ...

This Management's Discussion and Analysis dated January 11, 2023 (this "MD&A"), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the "Interim Financial Statements") of Organigram Holdings Inc. (the "Company" or "Organigram") for the three months ended November 30, 2022 ("Q1 Fiscal 2023") and the audited annual consolidated financial statements for the year ended August 31, 2022 (the "Annual Financial Statements"), including the accompanying notes thereto. ...

👍ORGANIGRAM INVESTOR PRESENTATION NASDAQ (OGI) TSX (OGI) Q4 Fiscal 2022 11 | 29 | 22 1 CAUTIONARY STATEMENT This document is current as of November 28, 2022, except where otherwise stated. The information contained in this presentation is provided by Organigram Holdings Inc. ("Organigram" or the "Company") for informational purposes only and does not constitute an offer to issue or arrange to issue, or the solicitation of an offer to issue, securities of Organigram or other financial products. No part of th ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2022 Results Conference Call November 29, 2022 8:00 AM ET Company Participants Craig MacPhail - Group Director, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Tamy Chen - BMO Capital Markets Ty Collin - Eight Capital Aaron Grey - Alliance Global Partners Andrew Partheniou - Stifel Matt Bottomley - Canaccord Genuity Michael Freeman - Raymond James Frederico Gomes - ATB Operator Go ...

ORGANIGRAM HOLDINGS INC. CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION As at May 31, 2022 and August 31, 2021 (Unaudited - expressed in CDN $000's except share and per share amounts) TABLE OF CONTENTS | | | MAY 31, | | AUGUST 31, | | --- | --- | --- | --- | --- | | | | 2022 | | 2021 (Note 30) | | ASSETS | | | | | | Current assets | | | | | | Cash | $ | 127,336 | $ | 55,365 | | Short-term investments (Note 4) | | 20 | | 128,190 | | Accounts receivable (Note 5) | | 34,535 | | 21,035 | | Loan ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q3 2022 Earnings Conference Call July 14, 2022 8:00 AM ET Company Participants Craig MacPhail - Group Director, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Rupesh Parikh - Oppenheimer& Co. Andrew Partheniou - Stifel GMP Aaron Grey - Alliance Global Partners Ty Collin - Eight Capital Matt Bottomley - Canaccord Genuity Frederico Gomes - ATB Capital Markets Tamy Chen - BMO Capital M ...

OrganiGram Holdings Inc. (NASDAQ:OGI) Q2 2022 Earnings Conference Call April 12, 2022 8:00 AM ET Company Participants Craig MacPhail - Group Director, NATIONAL Capital Markets Beena Goldenberg - Chief Executive Officer Derrick West - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Matt Bottomley - Canaccord Genuity Douglas Miehm - RBC Capital Markets Ty Collin - Eight Capital Frederico Gomes - ATB Capital Markets Owen Bennett - Jeffe ...